跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
X1
首页
药物
X1
X1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antibacterial peptide X1-3, pharmaceutical composition and application of antibacterial peptide X1-3
申请人: UNIV NORTHWEST A&F
优先权: 2026
CN
Recycling method of X1 crystal
申请人: MEISIDE JILIN NEW MAT CO LTD
优先权: 2024
CN
SMALL MOLECULE BCL-X1/BCL-2 BINDING INHIBITORS
申请人: CHEN CHING-SHIH
优先权: 2010
US
Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof
申请人: BAYER SCHERING PHARMA AG
优先权: 2003
US
5 件公开
Stabilized peptide fragments from nucleoredoxin X1 and uses thereof
申请人: UNIV TEMPLE
优先权: 2015
US
Novel gene editing protein Cas12a-X, mutant Cas12a-X1 thereof and application of novel gene editing protein Cas12a-X and mutant Cas12a-X1
申请人: INST ANIMAL SCIENCES CAAS
优先权: 2025
CN
GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2020
EP
US
WO
3 件公开
Corn grain size regulation gene X1 and SNP marker and application thereof
申请人: INST CROP SCIENCE CAAS
优先权: 2025
CN
药物
反馈